Use of positron emission tomography to study tumors in vivo
- 1 December 1996
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 2 (12) , 528-534
- https://doi.org/10.1016/s1357-4310(97)81457-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- MRI-PET Registration with Automated AlgorithmJournal of Computer Assisted Tomography, 1993
- Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucoseCancer, 1993
- The role of positron emission tomography in oncology and other whole-body applicationsSeminars in Nuclear Medicine, 1992
- The origins of positron emission tomographySeminars in Nuclear Medicine, 1992
- Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomographyAnnals of Neurology, 1991
- Advances in medical imaging for cancer diagnosis and treatmentCancer, 1991
- Positron Emission Tomography in the Detection of Malignant Degeneration of Low-Grade GliomasNeurosurgery, 1988
- Glucose utilization of cerebral gliomas measured by [ 18 F] fluorodeoxyglucose and positron emission tomographyNeurology, 1982
- Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of methodAnnals of Neurology, 1979
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977